Literature DB >> 20386999

Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats.

Prasanth K Chelikani1, Imran H Shah, Esmaeel Taqi, David L Sigalet, Henry H Koopmans.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is one of the most effective treatments for obesity producing long-term weight loss. The anorexia and weight loss from RYGB could be due to gastric restriction, malabsorption, enhanced lower gut stimulation, increased energy expenditure, and/or other metabolic adaptations. In ileal transposition (IT) surgery, a segment of the ileum is transposed to the upper jejunum with no gastric restriction or malabsorption. Our objective is to compare the effects of RYGB and IT surgeries on food intake, body weight, and plasma concentrations of the anorexigenic lower gut hormone Peptide YY (PYY) in rats.
METHODS: Adult male Sprague-Dawley rats were subjected to either RYGB (n = 9), IT (n = 9) or sham surgeries (n = 16). A subset of sham animals were either pair-fed to RYGB (n = 9) or ad lib fed (n = 7) on a highly palatable mixed nutrient liquid food (Ensure). Food intake, body weight and plasma PYY concentrations were measured.
RESULTS: The data demonstrate that (1) RYGB produces a sustained reduction in food intake and weight gain, (2) the anorexic effects of IT are relatively transient lasting for 5 weeks, (3) the reduction in weight gain resulting from IT is similar to that of animals pair-fed to RYGB, and (4) RYGB and IT surgeries are associated with elevated postprandial plasma PYY concentrations.
CONCLUSIONS: We demonstrate in our rat models that RYGB surgery produces a greater reduction in food intake and weight gain than IT surgery, and that both surgeries are associated with enhanced plasma concentrations of Peptide YY.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386999     DOI: 10.1007/s11695-010-0139-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  50 in total

1.  Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.

Authors:  Susumu Suzuki; Eduardo J B Ramos; Carolina G Goncalves; Chung Chen; Michael M Meguid
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

Authors:  Prasanth K Chelikani; Alvin C Haver; Joseph R Reeve; David A Keire; Roger D Reidelberger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-06       Impact factor: 3.619

Review 3.  Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

Authors:  Hutan Ashrafian; Carel W le Roux
Journal:  Physiol Behav       Date:  2009-03-20

4.  Medicine. Bypassing medicine to treat diabetes.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2008-04-25       Impact factor: 47.728

Review 5.  Current status of medical and surgical therapy for obesity.

Authors:  E C Mun; G L Blackburn; J B Matthews
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats.

Authors:  April D Strader; Trine Ryberg Clausen; Sean Z Goodin; Donna Wendt
Journal:  Obes Surg       Date:  2008-11-07       Impact factor: 4.129

7.  Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function.

Authors:  Ana Guijarro; Douglas Osei-Hyiaman; Judith Harvey-White; George Kunos; Susumu Suzuki; Sergiy Nadtochiy; Paul S Brookes; Michael M Meguid
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

8.  Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.

Authors:  Blanca Oliván; Julio Teixeira; Mousumi Bose; Baani Bawa; Tangel Chang; Heather Summe; Hongchan Lee; Blandine Laferrère
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

9.  Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.

Authors:  A L DePaula; A L V Macedo; B R Mota; V Schraibman
Journal:  Surg Endosc       Date:  2008-10-02       Impact factor: 4.584

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

View more
  20 in total

1.  Reduced sweet and fatty fluid intake after Roux-en-Y gastric bypass in rats is dependent on experience without change in stimulus motivational potency.

Authors:  Clare M Mathes; Ryan A Bohnenkamp; Carel W le Roux; Alan C Spector
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

2.  Remission of insulin resistance in type 2 diabetic patients after gastric bypass surgery or exenatide therapy.

Authors:  Wang Yong; Wei Shibo; Liu Jingang
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

Review 3.  Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity.

Authors:  Karen K Ryan; Stephen C Woods; Randy J Seeley
Journal:  Cell Metab       Date:  2012-01-11       Impact factor: 27.287

4.  Roux-en-Y gastric bypass in rats progressively decreases the proportion of fat calories selected from a palatable cafeteria diet.

Authors:  Clare M Mathes; Chanel Letourneau; Ginger D Blonde; Carel W le Roux; Alan C Spector
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-02-10       Impact factor: 3.619

5.  Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.

Authors:  Jie Chai; Guangyong Zhang; Shaozhuang Liu; Chunxiao Hu; Haifeng Han; Sanyuan Hu; Zongli Zhang
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

6.  GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

Authors:  Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

Review 7.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

8.  Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB).

Authors:  Dong Sun; Shaozhuang Liu; Guangyong Zhang; Weijie Chen; Zhibo Yan; Sanyuan Hu
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

9.  Biliopancreatic Limb Length of Small Intestinal Bypass in Non-obese Goto-Kakizaki (GK) Rats Correlates with Gastrointestinal Hormones, Adipokines, and Improvement in Type 2 Diabetes.

Authors:  Qiwei Zhang; Zhi Hong; Jieyao Zhu; Chao Zeng; Zhen Tang; Weiqiang Wang; He Huang
Journal:  Obes Surg       Date:  2021-07-26       Impact factor: 4.129

10.  Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats.

Authors:  A R Ramzy; S Nausheen; P K Chelikani
Journal:  Int J Obes (Lond)       Date:  2013-10-29       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.